The ratio of CD8⁺/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

References

• Denkert C, Loibl S, Noske A, Roller M, Muller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28:105-13; PMID:19917869; http://dx.doi.org/10.1200/JCO.2009.23.7370
   PubMed Web of Science ®Google Scholar
• Denkert C, von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD et al. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. J Clin Oncol 2015; 33:983-91; PMID:25534375; http://dx.doi.org/10.1200/JCO.2014.58.1967
   PubMed Web of Science ®Google Scholar
• Dieci MV, Mathieu MC, Guarneri V, Conte P, Delaloge S, Andre F, Goubar A. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials. Ann Oncol 2015; 26:1698-704; PMID:25995301; http://dx.doi.org/10.1093/annonc/mdv239
   PubMed Web of Science ®Google Scholar
• Dieci MV, Criscitiello C, Goubar A, Viale G, Conte P, Guarneri V, Ficarra G, Mathieu MC, Delaloge S, Curigliano G et al. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol 2015; 26:1518; PMID:26109735; http://dx.doi.org/10.1093/annonc/mdv239
   PubMed Web of Science ®Google Scholar
• Kroemer G, Senovilla L, Galluzzi L, Andre F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med 2015; 21:1128-38; PMID:26444637; http://dx.doi.org/10.1038/nm.3944
   PubMed Web of Science ®Google Scholar
• Ingold Heppner B, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmitt WD, Eidtmann H, Fasching PA, Tesch H, Solbach C et al. Tumor-infiltrating lymphocytes: a predictive and prognostic biomarker in neoadjuvant treated HER2-positive breast cancer. Clin Cancer Res 2016; PMID:27189162; http://dx.doi.org/10.1158/1078-0432.CCR-15-2338
   PubMed Web of Science ®Google Scholar
• Ingold Heppner B, Loibl S, Denkert C. Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer. Breast Care (Basel) 2016; 11:96-100; PMID:27239170; http://dx.doi.org/10.1159/000444357
   PubMed Web of Science ®Google Scholar
• Stoll G, Enot D, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunol 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884
   PubMed Web of Science ®Google Scholar
• Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier-Colame V, Chaba K, Semeraro M, Chaix M, Penault-Llorca F, Arnould L et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy 2016; 12:864-75; PMID:26979828; http://dx.doi.org/10.1080/15548627.2016.1154244
   PubMed Web of Science ®Google Scholar
• Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/science.1224922
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486
   PubMed Web of Science ®Google Scholar
• Palucka AK, Coussens LM. The Basis of Oncoimmunology. Cell 2016; 164:1233-47; PMID:26967289; http://dx.doi.org/10.1016/j.cell.2016.01.049
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell 2016; 165:276-87; PMID:27058662; http://dx.doi.org/10.1016/j.cell.2016.03.001
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437:1043-7; PMID:16222300; http://dx.doi.org/10.1038/nature04217
   PubMed Web of Science ®Google Scholar
• Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J, Mermel CH et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013; 45:1134-40; PMID:24071852; http://dx.doi.org/10.1038/ng.2760
   PubMed Web of Science ®Google Scholar
• Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaa M, Castedo M, Kroemer G. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 2011; 18:1403-13; PMID:21072053; http://dx.doi.org/10.1038/cdd.2010.145
   PubMed Web of Science ®Google Scholar
• Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buque A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L et al. eIF2alpha phosphorylation as a biomarker of immunogenic cell death. Semin Cancer Biol 2015; 33:86-92; PMID:25749194; http://dx.doi.org/10.1016/j.semcancer.2015.02.004
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28:578-90; PMID:19165151; http://dx.doi.org/10.1038/emboj.2009.1
   PubMed Web of Science ®Google Scholar
• Boileve A, Senovilla L, Vitale I, Lissa D, Martins I, Metivier D, van den Brink S, Clevers H, Galluzzi L, Castedo M et al. Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell Cycle 2013; 12:473-9; PMID:23324343; http://dx.doi.org/10.4161/cc.23369
   PubMed Web of Science ®Google Scholar
• Senovilla L, Vitale I, Martins I, Kepp O, Galluzzi L, Zitvogel L, Castedo M, Kroemer G. An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells. Oncoimmunol 2013; 2:e22409; PMID:23482968; http://dx.doi.org/10.4161/onci.22409
   PubMed Web of Science ®Google Scholar
• Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L et al. Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev 2013; 24:311-8; PMID:23787159; http://dx.doi.org/10.1016/j.cytogfr.2013.05.001
   PubMed Web of Science ®Google Scholar
• Bloy N, Sauvat A, Chaba K, Buque A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L et al. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget 2015; 6:41204-15; PMID:26517677; http://dx.doi.org/10.18632/oncotarget.5400
   PubMed Web of Science ®Google Scholar
• Shah C, Wobb J, Manyam B, Kundu N, Arthur D, Wazer D, Fernandez E, Vicini F. Management of Ductal Carcinoma in Situ of the Breast: A Review. JAMA Oncol 2016; PMID:27253401; http://dx.doi.org/10.1001/jamaoncol.2016.0525
   PubMed Web of Science ®Google Scholar
• Decker MR, Trentham-Dietz A, Loconte NK, Neuman HB, Smith MA, Punglia RS, Greenberg CC, Wilke LG. The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ. Ann Surg Oncol 2016; PMID:27026436; http://dx.doi.org/10.1245/s10434-016-5192-5
   PubMed Web of Science ®Google Scholar
• Morita M, Yamaguchi R, Tanaka M, Tse GM, Yamaguchi M, Kanomata N, Naito Y, Akiba J, Hattori S, Minami S et al. CD8 tumor-infiltrating lymphocytes contribute to spontaneous “healing” in HER2-positive ductal carcinoma in situ. Cancer Med 2016; 5:1607-18; PMID:27061242; http://dx.doi.org/10.1002/cam4.715
   PubMed Web of Science ®Google Scholar
• Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol 2016; 29:249-58; PMID:26769139; http://dx.doi.org/10.1038/modpathol.2015.158
   PubMed Web of Science ®Google Scholar
• Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Res 2016; 76:1746-56; PMID:26842877; http://dx.doi.org/10.1158/0008-5472.CAN-15-1142
   PubMed Web of Science ®Google Scholar
• Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Mariño G, Lachkar S, Senovilla L et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell 2012; 48:667-80; PMID:23084476; http://dx.doi.org/10.1016/j.molcel.2012.09.013
   PubMed Web of Science ®Google Scholar
• Wemeau M, Kepp O, Tesniere A, Panaretakis T, Flament C, De Botton S, Zitvogel L, Kroemer G, Chaput N. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia. Cell Death Dis 2010; 1:e104; PMID:21368877; http://dx.doi.org/10.1038/cddis.2010.82
   PubMed Web of Science ®Google Scholar
• van Der Laak JA, Pahlplatz MM, Hanselaar AG, de Wilde PC. Hue-saturation-density (HSD) model for stain recognition in digital images from transmitted light microscopy. Cytometry 2000; 39:275-84; PMID:10738280; http://dx.doi.org/10.1002/(SICI)1097-0320(20000401)39:4%3c275::AID-CYTO5%3e3.0.CO;2-8
   PubMedGoogle Scholar
• Rusakiewicz S, Semeraro M, Sarabi M, Desbois M, Locher C, Mendez R, Vimond N, Concha A, Garrido F, Isambert N et al. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Cancer Res 2013; 73:3499-510; PMID:23592754; http://dx.doi.org/10.1158/0008-5472.CAN-13-0371
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C et al. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget 2015; 6:20840-50; PMID:26369701; http://dx.doi.org/10.18632/oncotarget.4428
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G. Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells. Oncoimmunol 2016; 5:e1064581; PMID:27057430; http://dx.doi.org/10.1080/2162402X.2015.1064581
   PubMed Web of Science ®Google Scholar